# Donor Umbilical Cord Blood Transplant After Cyclophosphamide, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematologic Disease

> **NCT00959231** · PHASE2 · UNKNOWN · sponsor: **Cancer Research UK** · enrollment: 60 (estimated)

## Conditions studied

- Hematopoietic/Lymphoid Cancer

## Interventions

- **DRUG:** cyclophosphamide
- **DRUG:** cyclosporine
- **DRUG:** fludarabine phosphate
- **DRUG:** mycophenolate mofetil
- **OTHER:** laboratory biomarker analysis
- **PROCEDURE:** nonmyeloablative allogeneic hematopoietic stem cell transplantation
- **PROCEDURE:** umbilical cord blood transplantation
- **RADIATION:** total-body irradiation

## Key facts

- **NCT ID:** NCT00959231
- **Lead sponsor:** Cancer Research UK
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-01
- **Primary completion:** 2012-08
- **Final completion:** —
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2013-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00959231

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00959231, "Donor Umbilical Cord Blood Transplant After Cyclophosphamide, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematologic Disease". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00959231. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*